Hilary R. Keller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hilary R. Keller has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Jung-Hyun Park
Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
3 shared publications Danny Lascano
Saint John's Cancer Institute (formerly John Wayne Cancer Institute), Saint John's Health Center, Santa Monica, CA, USA
2 shared publicationsDouglas A. Hanes
Saint John's Cancer Institute (formerly John Wayne Cancer Institute), Saint John's Health Center, Santa Monica, CA, USA
2 shared publicationsJillian K. McCabe
Saint John's Cancer Institute (formerly John Wayne Cancer Institute), Saint John's Health Center, Santa Monica, CA, USA
2 shared publicationsPaul Shin
Saint John's Cancer Institute (formerly John Wayne Cancer Institute), Saint John's Health Center, Santa Monica, CA, USA; Borstein Family Melanoma Program, Laboratory of Cutaneous Oncology, Santa Monica, CA, USA
2 shared publicationsAnthony Morada
Department of Surgery, Guthrie Robert Packer Hospital, Sayre, PA, 18840, USA
1 shared publication
Latest Publications
- 5 November 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 251, 116709
Impact of non-metropolitan residence on survival for gastric neuroendocrine tumors
- 5 November 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 251, 116709
Impact of non-metropolitan residence on survival for gastric neuroendocrine tumors
- 5 November 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 251, 116710
Male or female sex stratified by age does not impact survival in patients with metastatic melanoma receiving immunotherapy
- 5 November 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 251, 116710
Male or female sex stratified by age does not impact survival in patients with metastatic melanoma receiving immunotherapy
- Open Access
- 18 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6627
Integrin CD103 reveals a distinct developmental pathway of autoreactive thymocytes in TCR transgenic mice
Clonal deletion through negative selection is critical to eliminate autoreactive T cells in the thymus. Negative selection, however, is imperfect such that some autoreactive thymocytes can escape thymic deletion and successfully populate peripheral tissues. This is also the case for autoreactive 2D2 TCR transgenic T cells, a widely employed mouse model in studying the pathogenesis of CD4 T cell-mediated experimental autoimmune encephalomyelitis. How autoreactive 2D2 thymocytes evade negative selection, however, remains incompletely understood. Here we show that negative selection of MHC-II-restricted thymocytes, specifically 2D2 TCR transgenic T cells, is associated with the induction of integrin CD103, and that forced expression of CD103 downregulates CXCR4 expression, alters intra-thymic trafficking, and reinforces clonal deletion of immature thymocytes. Stratification of positively versus negatively selected 2D2 T cells based on their distinct coreceptor expression further shows that CD103 does not affect the generation of conventional CD4 T cells but is deleterious for autoreactive CD4, CD8 double-negative 2D2 T cells that correspond to CD69-negative CCR7-intermediate thymocytes, displaying markers of agonistic TCR signalling. Collectively, these results propose CD103 expression as an indicator and contributor of negative selection for MHC-II-restricted T cells, providing further mechanistic insights into the process of T cell selection in the thymus.
- 18 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6627
Open AccessIntegrin CD103 reveals a distinct developmental pathway of autoreactive thymocytes in TCR transgenic mice
Clonal deletion through negative selection is critical to eliminate autoreactive T cells in the thymus. Negative selection, however, is imperfect such that some autoreactive thymocytes can escape thymic deletion and successfully populate peripheral tissues. This is also the case for autoreactive 2D2 TCR transgenic T cells, a widely employed mouse model in studying the pathogenesis of CD4 T cell-mediated experimental autoimmune encephalomyelitis. How autoreactive 2D2 thymocytes evade negative selection, however, remains incompletely understood. Here we show that negative selection of MHC-II-restricted thymocytes, specifically 2D2 TCR transgenic T cells, is associated with the induction of integrin CD103, and that forced expression of CD103 downregulates CXCR4 expression, alters intra-thymic trafficking, and reinforces clonal deletion of immature thymocytes. Stratification of positively versus negatively selected 2D2 T cells based on their distinct coreceptor expression further shows that CD103 does not affect the generation of conventional CD4 T cells but is deleterious for autoreactive CD4, CD8 double-negative 2D2 T cells that correspond to CD69-negative CCR7-intermediate thymocytes, displaying markers of agonistic TCR signalling. Collectively, these results propose CD103 expression as an indicator and contributor of negative selection for MHC-II-restricted T cells, providing further mechanistic insights into the process of T cell selection in the thymus.
- 1 October 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 225 (1) , 58-65
Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine
- 1 October 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 225 (1) , 58-65
Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine
- Open Access
- 8 November 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (21)
The small intestine epithelium exempts Foxp3+ Tregs from their IL-2 requirement for homeostasis and effector function
Foxp3 + Tregs are potent immunosuppressive CD4 + T cells that are critical to maintain immune quiescence and prevent autoimmunity. Both the generation and maintenance of Foxp3 + Tregs depend on the cytokine IL-2. Hence, the expression of the IL-2 receptor α -chain (CD25) is not only considered a specific marker, but also a nonredundant requirement for Tregs. Here, we report that Foxp3 + Tregs in the small intestine (SI) epithelium, a critical barrier tissue, are exempt from such an IL-2 requirement, since they had dramatically downregulated CD25 expression, showed minimal STAT5 phosphorylation ex vivo, and were unable to respond to IL-2 in vitro. Nonetheless, SI epithelial Tregs survived and were present at the same frequency as in other lymphoid organs, and they retained potent suppressor function that was associated with high levels of CTLA-4 expression and the production of copious amounts of IL-10. Moreover, adoptive transfer experiments of Foxp3 + Tregs revealed that such IL-2–independent survival and effector functions were imposed by the SI epithelial tissue, suggesting that tissue adaptation is a mechanism that tailors the effector function and survival requirements of Foxp3 + Tregs specific to the tissue environment.
- 8 November 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (21)
Open AccessThe small intestine epithelium exempts Foxp3+ Tregs from their IL-2 requirement for homeostasis and effector function
Foxp3 + Tregs are potent immunosuppressive CD4 + T cells that are critical to maintain immune quiescence and prevent autoimmunity. Both the generation and maintenance of Foxp3 + Tregs depend on the cytokine IL-2. Hence, the expression of the IL-2 receptor α -chain (CD25) is not only considered a specific marker, but also a nonredundant requirement for Tregs. Here, we report that Foxp3 + Tregs in the small intestine (SI) epithelium, a critical barrier tissue, are exempt from such an IL-2 requirement, since they had dramatically downregulated CD25 expression, showed minimal STAT5 phosphorylation ex vivo, and were unable to respond to IL-2 in vitro. Nonetheless, SI epithelial Tregs survived and were present at the same frequency as in other lymphoid organs, and they retained potent suppressor function that was associated with high levels of CTLA-4 expression and the production of copious amounts of IL-10. Moreover, adoptive transfer experiments of Foxp3 + Tregs revealed that such IL-2–independent survival and effector functions were imposed by the SI epithelial tissue, suggesting that tissue adaptation is a mechanism that tailors the effector function and survival requirements of Foxp3 + Tregs specific to the tissue environment.
- Open Access
- 11 May 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (12) , 3227-3235
The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells
Lymphopenia-induced homeostatic proliferation (LIP) is a critical mechanism for restoring T cell immunity upon lymphodepleting insults or infections. LIP is primarily driven by homeostatic cytokines, such as IL-7 and IL-15, but not all T cells respond with the same efficiency to homeostatic proliferative cues. Although CD8 T cells vigorously proliferate under lymphopenic conditions, naive CD4 T cells are substantially impaired in their response to homeostatic cytokines, and they fail to fully expand. In this study, we show that the availability of IL-2Rβ (CD122), which is a receptor subunit shared by IL-2 and IL-15, affects both the cytokine responsiveness and the LIP of naive CD4 T cells in the mouse. The enumeration of surface IL-2Rβ molecules on murine naive CD4 and naive CD8 T cells revealed a 5-fold difference in IL-2Rβ abundance. Notably, it was the limited availability of IL-2Rβ that impaired CD4 T cell responsiveness to IL-15 and suppressed their LIP. As such, forced IL-2Rβ expression on CD4 T cells by transgenesis bestowed IL-15 responsiveness onto naive CD4 T cells, which thus acquired the ability to undergo robust LIP. Collectively, these results identify IL-2Rβ availability as a new regulatory mechanism to control cytokine responsiveness and the homeostatic proliferation of murine CD4 T cells.
- 11 May 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (12) , 3227-3235
Open AccessThe Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells
Lymphopenia-induced homeostatic proliferation (LIP) is a critical mechanism for restoring T cell immunity upon lymphodepleting insults or infections. LIP is primarily driven by homeostatic cytokines, such as IL-7 and IL-15, but not all T cells respond with the same efficiency to homeostatic proliferative cues. Although CD8 T cells vigorously proliferate under lymphopenic conditions, naive CD4 T cells are substantially impaired in their response to homeostatic cytokines, and they fail to fully expand. In this study, we show that the availability of IL-2Rβ (CD122), which is a receptor subunit shared by IL-2 and IL-15, affects both the cytokine responsiveness and the LIP of naive CD4 T cells in the mouse. The enumeration of surface IL-2Rβ molecules on murine naive CD4 and naive CD8 T cells revealed a 5-fold difference in IL-2Rβ abundance. Notably, it was the limited availability of IL-2Rβ that impaired CD4 T cell responsiveness to IL-15 and suppressed their LIP. As such, forced IL-2Rβ expression on CD4 T cells by transgenesis bestowed IL-15 responsiveness onto naive CD4 T cells, which thus acquired the ability to undergo robust LIP. Collectively, these results identify IL-2Rβ availability as a new regulatory mechanism to control cytokine responsiveness and the homeostatic proliferation of murine CD4 T cells.
- 20 April 2020
- Published by University of Queensland Library
Resistance to therapy in metastatic melanoma: comparing the expression of immune inhibitory modulators in vitro with refractory metastatic melanoma patients
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.
- 20 April 2020
- Published by University of Queensland Library
Resistance to therapy in metastatic melanoma: comparing the expression of immune inhibitory modulators in vitro with refractory metastatic melanoma patients
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.